BR0212261A - Composto, processo para a preparação e utilização desse composto - Google Patents

Composto, processo para a preparação e utilização desse composto

Info

Publication number
BR0212261A
BR0212261A BR0212261-8A BR0212261A BR0212261A BR 0212261 A BR0212261 A BR 0212261A BR 0212261 A BR0212261 A BR 0212261A BR 0212261 A BR0212261 A BR 0212261A
Authority
BR
Brazil
Prior art keywords
compound
preparing
protecting group
group
diols
Prior art date
Application number
BR0212261-8A
Other languages
English (en)
Inventor
Brian David Judkins
Simon John Fawcett Macdonald
Derek Anthony Demaine
Graham George Adam
Julie Nicole Hamblin
Original Assignee
Biota Scient Management
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Scient Management filed Critical Biota Scient Management
Publication of BR0212261A publication Critical patent/BR0212261A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)

Abstract

"COMPOSTO, PROCESSO PARA A PREPARAçãO E UTILIZAçãO DESSE COMPOSTO". Expõem-se compostos da fórmula (I), processos para a sua preparação e sua utilização na manufatura de conjugados inibidores de neuraminidase, em que R representa um grupo de proteção de ácido carboxílico; P~ 1~ e P~ 2~ podem ser o mesmo ou diferentes e são selecionados a partir de grupos de proteção de amina; P~ 3~ representa um grupo de proteção para 1,2 dióis; e LG representa um grupo retirante.
BR0212261-8A 2001-09-07 2002-08-30 Composto, processo para a preparação e utilização desse composto BR0212261A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR757401 2001-09-07
PCT/AU2002/001187 WO2003022841A1 (en) 2001-09-07 2002-08-30 Intermediates for preparing neuraminidase inhibitor conjugates

Publications (1)

Publication Number Publication Date
BR0212261A true BR0212261A (pt) 2004-10-19

Family

ID=3831510

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0212261-8A BR0212261A (pt) 2001-09-07 2002-08-30 Composto, processo para a preparação e utilização desse composto

Country Status (12)

Country Link
US (1) US7230114B2 (pt)
EP (1) EP1423385B1 (pt)
JP (1) JP4463553B2 (pt)
AT (1) ATE399779T1 (pt)
BR (1) BR0212261A (pt)
CA (1) CA2456239C (pt)
DE (1) DE60227386D1 (pt)
DK (1) DK1423385T3 (pt)
ES (1) ES2307776T3 (pt)
MX (1) MXPA04002141A (pt)
PT (1) PT1423385E (pt)
WO (1) WO2003022841A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015032357A1 (zh) * 2013-09-09 2015-03-12 中国科学院上海有机化学研究所 扎那米韦和拉那米韦的中间体及其合成方法
CN113461631B (zh) * 2021-06-29 2022-10-14 上海应用技术大学 一种1,3,4-恶二唑类神经氨酸酶抑制剂及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9516276D0 (en) * 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
ATE238552T1 (de) 1996-03-01 2003-05-15 Biota Scient Management Verfahren zum nachweis von influenza-virus und dazu verwendbare verbindungen
ATE239006T1 (de) * 1996-08-13 2003-05-15 Sankyo Co Verbindungen der neuraminsaeure
AUPR001000A0 (en) * 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use

Also Published As

Publication number Publication date
PT1423385E (pt) 2008-09-24
CA2456239A1 (en) 2003-03-20
ES2307776T3 (es) 2008-12-01
US7230114B2 (en) 2007-06-12
DK1423385T3 (da) 2008-11-03
JP4463553B2 (ja) 2010-05-19
MXPA04002141A (es) 2004-07-23
ATE399779T1 (de) 2008-07-15
US20050032853A1 (en) 2005-02-10
CA2456239C (en) 2010-11-30
EP1423385A1 (en) 2004-06-02
WO2003022841A1 (en) 2003-03-20
JP2005501921A (ja) 2005-01-20
DE60227386D1 (de) 2008-08-14
EP1423385B1 (en) 2008-07-02
EP1423385A4 (en) 2004-12-01

Similar Documents

Publication Publication Date Title
BR0210464A (pt) Composto, composição farmacêutica, processo para preparar um composto, e, uso de um composto
BR0206433A (pt) Composto, composição farmacêutica, processo para a prepapação de um composto, e, uso de um composto
BR0010555A (pt) Inibidores de neuraminidases
BR0309546A (pt) Composto, composição farmacêutica que compreende o mesmo, processo para a sua preparação e utilização e método para tratamento profilático ou terapêutico de diabetes do tipo ii
BR0314113A (pt) Derivados de amino propanol
BR0114576A (pt) Composto, composição farmacêutica, uso de um composto, método de tratar um estado doentio e processo para preparar um composto
BR9707958A (pt) Composto, composição farmacêutica, e, processo para tratar hiperalgesia em um paciente.
BR0214559A (pt) sais de ácido succìnico do 5,8,14-triazatetraciclo [10.3.1.0<2,11>.0<4,9>]-hexadeca-2(11),3,5,7,9-penteno e suas composições farmacêuticas
BR9916633A (pt) Benzopiranos e benzoxepinas, composições farmacêuticas compreendendo-as e processo de preparação
BR0212069A (pt) Agentes antidiabéticos orais
BR0211422A (pt) Processo para a preparação de um composto ou de um éster ou um sal do mesmo, e, composto
BR0213481A (pt) Sondas
BR9708233A (pt) Processo para sìntese de um composto e composto.
BRPI0512951A (pt) compostos, processo para sua fabricação, composições farmacêuticas contendo os mesmos, uso e método para tratamento e/ou prevenção de doenças que são moduladas pelos agonistas de ppar(delta) e/ou ppar(alpha)
BRPI0411308A (pt) composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto
BR0012631A (pt) Processo para a preparação de compostos de amina
BR0210278A (pt) Processo para a preparação de l-ribavirina
BR9705456A (pt) Compostos heterocìclicos, processo de aminometila para sua preparação e composições farmacêuticas que os contêm.
BR9813217A (pt) Tetraciclos, processo para a produção dos mesmos e preparações farmacêuticas contendo estes compostos
BR0007982A (pt) Processo para a preparação de um composto, e,composto
BR9911250A (pt) Processo para preparação de compostos
BR0113259A (pt) Processo para a preparação de um composto, composto e processo para a preparação de compostos
BR0212261A (pt) Composto, processo para a preparação e utilização desse composto
BR0308601A (pt) inibidores de carboxipeptidase b de plasma
BR0114258A (pt) Esteróides de 17alfa-fluoroalquila, processo para sua produção e composições farmacêuticas que contêm estes compostos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA INT.CL: C07D 407/06, C07D 407/14, A61P 31/00

Ipc: C07D 407/06 (2011.01), C07D 407/14 (2011.01)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2269 DE 01/07/2014.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.